Skip to content

GeneMind Sequencing Platform Provide High-quality WGBS Sequencing Data with 0% PhiX Library Spike in

Background:

The base composition of Whole Genome Bisulfite Sequencing (WGBS) libraries exhibits a severe imbalance (GC content of approximately 20%), posing significant challenges for delivering high-quality WGBS sequencing data. Conventionally, this issue is mitigated by incorporating high proportions of specialized balanced libraries (e.g., PhiX or E. coli libraries) or co-sequencing with samples featuring 40%-50% GC content. However, these methods reduce production efficiency and increase sequencing costs and operational complexity.

Methylation sequencing plays a pivotal role in early tumor screening by detecting epigenetic alterations that precede genetic mutations. It offers a non-invasive and highly sensitive approach for cancer detection at its earliest stages. GeneMind high-throughput sequencing platforms(GenoLab M, FASTASeq 300, and SURFSeq 5000) have achieved high-quality sequencing with “0% Phix library spike in.” In this test, under 0% PhiX spike in conditions, the system demonstrated a mean Q30 ≥92% and a mean single-index demultiplexing rate ≥98%, delivering data performance comparable to the competitor NV platform when mixed with balanced libraries.

Experiment Design:

Sequencing PlatformProportion of PhiX Spike in RepeatsSample ID
FASTASeq 3000%31_FA, 2_FA, 3_FA
20% PhiX1PhiX_FA
GenoLab M0%31_GL, 2_GL, 3_GL
20% PhiX1PhiX_GL
SURFSeq 50000%31_SF, 2_SF, 3_SF
Competitor NV80% Phix31_NV, 2_NV, 3_NV

Result:

Fig 1: Data performance of FASTASeq 300_0% PhiX spike in

Fig 2: Data performance of GenoLab M_0% PhiX spike in

Fig 3: Data performance of SURFSeq 5000_0% PhiX spike in

Fig 4: Mapping rate in FASTASeq 300 and GenoLab M platform

Fig 5: Mapping rate in SURFSeq 5000 and competitor NV platform

Fig 6. Distribution ratios of methylation types

Fig 7: Methylation level of CG in whole genome

Conclusion:

GeneMind has achieved high-quality WGBS sequencing data with “0% PhiX library spike in” across all NGS product lines through technology optimization and upgrades. This breakthrough has further enhanced the product competitiveness of GeneMind sequencing platforms by providing end-users with highly efficient, cost-effective sequencing solutions.

Recently Articles